ÂÜÀòÂÒÂ×

Ted Henderson is a Managing Partner at Schooner Capital, a Boston-based investment firm that was founded in 1971 and operates with a permanent capital base. Ted invests in venture and growth-stage companies while applying resources to firm strategy and asset allocation. Presently, Ted serves as a director at Zixi, Spotted Risk, Cartesian Therapeutics, SRS Medical, and Nanoscale Powders. He has led and served as a director at a number of former Schooner holdings, including Shift.io, 4G Clinical, Seventh Generation, Millstone Medical Outsourcing, Best Doctors, Topokine Therapeutics, and Stylefeeder. He received an MBA from Harvard Business School and is a cum laude graduate of Dartmouth College, with a degree in Chinese language and culture.